PRPH
USDProPhase Labs Inc. Common Stock (DE)
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.288
Kõrge
$0.288
Madal
$0.257
Maht
0.76M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
11.7M
Tööstusharu
Diagnostics & Research
Riik
United States
Kauplemisstatistika
Keskmine maht
6.45M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 10. nov 2025PRPH (ProPhase Labs Inc.) Market Analysis: Unlocking Value Despite Mixed Signals
News Sentiment Overview
Recent headlines highlight major validation for ProPhase Labs
Seotud uudised
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives
ProPhase Labs to Present at the 2025 ThinkEquity Conference
UNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics, and consumer products company, today announced that it will be
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH) ("ProPhase" or the
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 10. nov 2025, 09:37
58.2% Kindlus
Risk ja kauplemine
Sisenemispunkt
$0.27
Võta kasum
$0.33
Peata kahjum
$0.25
Põhitegurid
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.